Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia

NCT00231101 is registered in ClinicalTrials.gov with Arthur P. Noyes Research Foundation as lead sponsor.

NCT NCT00231101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00231101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia
Lead sponsor
Arthur P. Noyes Research Foundation
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2004
Completion date
June 30, 2006
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking behavior in schizophrenia